Matory W E, D'Orsi C, Moss L
Division of Plastic and Reconstructive Surgery, University of Massachusetts Medical Center, Worcester 01655.
Ann Plast Surg. 1994 Aug;33(2):119-27. doi: 10.1097/00000637-199408000-00001.
Several studies indicate that mammographic evaluation of the breast is inhibited by both submammary and submuscular implants, regardless of implant composition. Two hundred radiographs were evaluated following subpectoral placement of 25 combination gel/saline and 25 saline-filled tissue expanders. Within 3 months after augmentation, mammograms were performed using the standard and displacement techniques; patients with inflated implants were followed by a repeat displacement study (with the expander deflated). After completion of the mammogram, expanders were reinflated. Our experience demonstrates that better visualization of breast tissue may be accomplished by implant-deflated views in patients with small amounts of breast tissue, tight skin envelopes, or capsular contraction. In each of these circumstances, the displaced view failed to adequately demonstrate glandular tissue. The presence of the inflated implant impairs mammographic visualization in a number of ways, including implant opacity, impaired automatic exposure control, interference with breast compressibility, and implant displacement. These effects are consistently present in small breasts (< an estimated 300 g), in breasts with grade III or IV capsular contracture, and in breasts with minimal skin laxity (i.e., nonptotic breasts). Breast compression was compromised to a greater degree in the presence of grade III and IV capsular contracture; however, deflation of an adjustable implant optimized radiographic interpretation to a high degree. The deflatable saline implant yields a less obscured evaluation of the augmented breast. We suggest that an extended-use deflatable device (i.e., tissue expander) be considered as an option in our search for a safe and reliable implant for augmentation mammoplasty, particularly in patients with small breasts, tight skin envelopes, or a propensity for capsular contracture.
多项研究表明,无论植入物的成分如何,乳房下和胸大肌下植入物都会妨碍乳房的钼靶检查评估。在25个凝胶/盐水组合型和25个盐水填充型组织扩张器置于胸大肌下后,对200张X光片进行了评估。隆乳术后3个月内,采用标准技术和移位技术进行钼靶检查;对于植入物已充盈的患者,随后进行重复移位检查(扩张器放气)。钼靶检查完成后,扩张器重新充气。我们的经验表明,对于乳房组织量少、皮肤包膜紧绷或有包膜挛缩的患者,通过放气后的植入物视图可以更好地观察乳房组织。在上述每种情况下,移位视图均无法充分显示腺体组织。充盈的植入物会以多种方式损害钼靶检查的可视化效果,包括植入物的不透光性、自动曝光控制受损、对乳房可压缩性的干扰以及植入物移位。这些影响在小乳房(估计<300g)、III级或IV级包膜挛缩的乳房以及皮肤松弛度最小(即不下垂的乳房)的乳房中始终存在。在III级和IV级包膜挛缩的情况下,乳房压迫受到更大程度的影响;然而,可调节植入物的放气在很大程度上优化了影像学解读。可放气的盐水植入物对隆乳后的乳房评估干扰较小。我们建议,在寻求安全可靠的隆乳植入物时,特别是对于小乳房、皮肤包膜紧绷或有包膜挛缩倾向的患者,可考虑使用延长使用的可放气装置(即组织扩张器)。